Abiomed Impella RT-DAQ - 观察研究
Abiomed IMPELLA-RT-DAQ - Impella 实时数据采集
Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition
研究概览
详细说明
The objective of this study is to develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module, which can replace invasive hemodynamic monitoring in the future.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Kirstin Starke
- 电话号码:+49 241 8860
- 邮箱:KStarke@ITS.JNJ.com
学习地点
-
-
North Rhine-Westphalia
-
Aachen、North Rhine-Westphalia、德国、52074
- 主动,不招人
- Uniklinik RWTH Aachen
-
-
Schleswig-Holstein
-
Kiel、Schleswig-Holstein、德国、24105
- 招聘中
- UKSH Campus Kiel
-
首席研究员:
- Bernd Panholzer, MD
-
-
-
-
MI
-
Milan、MI、意大利、20132
- 招聘中
- IRCCS Ospedale San Raffaele
-
首席研究员:
- Alberto Zangrillo, MD
-
副研究员:
- Luca Baldetti, MD
-
-
-
-
-
Basel、瑞士
- 招聘中
- Universitätsspital Basel
-
接触:
- Patrick Hunziker, MD
-
首席研究员:
- Patrick Hunziker, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients requiring cardiac Impella pump-support and intensive care therapy including cardiac output monitoring, eg. by pulmonary artery catheter at some point of therapy.
Initially, a collection of 250 patient days is aimed for. It is expected that each patient will be monitored by PAC for at least 48 hours, thus approximately 125 patients will be needed to achieve study objectives.
描述
Inclusion Criteria:
-
Ongoing or planned intensive care management with Impella support
-
Presence or planned placement of a cardiac output measurement
- Preferentially pulmonary catheter (including cardiac output (CO) preferred as continuous measurement)
- Other means of discontinuous CO measurement incl. echocardiography, other thermodilution methods
Exclusion Criteria:
- Age < 18 years
- Pregnancy
- Anticipated support duration <24 h
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Collection of hemodynamic parameters (Cardiac Output in l/min)
大体时间:From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
Synchronous data acquisition of the Impella system parameters (pressure measurement, motor current, operating data) and the monitoring system (Philipps IntelliVue) using a network module (HighDim) that is connected by either a wired or wireless access. |
From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
|
Collection of hemodynamic parameters (Blood Pressure in mmHg, Pulmonary Artery Pressure in mmHg, Central Venous Pressure in mmHg, Pulmonary Capillary Wedge Pressure in mmHg)
大体时间:From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
Synchronous data acquisition of the Impella system parameters (pressure measurement, motor current, operating data) and the monitoring system (Philipps IntelliVue) using a network module (HighDim) that is connected by either a wired or wireless access. |
From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
|
Collection of hemodynamic parameters (Mixed Venous Saturation in %)
大体时间:From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
Synchronous data acquisition of the Impella system parameters (pressure measurement, motor current, operating data) and the monitoring system (Philipps IntelliVue) using a network module (HighDim) that is connected by either a wired or wireless access. |
From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
|
Collection of hemodynamic parameters (Pulmonary Vascular Resistance in In dynes/sec/cm-5 )
大体时间:From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
Synchronous data acquisition of the Impella system parameters (pressure measurement, motor current, operating data) and the monitoring system (Philipps IntelliVue) using a network module (HighDim) that is connected by either a wired or wireless access. |
From Impella insertion unitl Impella support is permanently weaned, on average 2 days
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
患者生存率
大体时间:一旦 Impella 支持永久断奶,平均需要 2 天
|
一旦 Impella 支持永久断奶,平均需要 2 天
|
合作者和调查者
赞助
调查人员
- 首席研究员:Alexander Kersten, MD、Uniklinik RWTH Aachen, Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.